Lysosomal enzymes in serum and synovial fluid in patients with osteoarthritis

References

• Bonnet CS, Walsh DA. Osteoarthritis, angiogenesis and inflammation. Rheumatology 2005;44:7–16.
   PubMed Web of Science ®Google Scholar
• Brooks P. Inflammation as an important feature of osteoarthritis. Bull WHO 2003;81:689–90.
   PubMed Web of Science ®Google Scholar
• Fitowska A, Ostałowska A, Dobrakowski M, Hapeta B, Kasperczyk A, Stołtny T, Koczy B, Swięchowicz S, Birkner E, Kasperczyk S. Protein metabolism in the synovial membrane in the hip osteoarthritis. Pol Orthop Traumatol 2012;77:21–6.
   PubMedGoogle Scholar
• Rousseau JC, Garnero P. Biomarkers in osteoarthritis. Bone 2012;51:265–77.
   PubMed Web of Science ®Google Scholar
• Lis K, Sypniewska G, Nowacki W. IGF-1, cytokines and biochemical bone turnover markers in synovial fluid and serum of patients with primary and secondary osteoarthritis of the hip. Biochem Med 2006;16:127–36.
   Google Scholar
• Schneider U, Schmidt-Rohlfing B, Knopf U, Breusch SU. Effects upon bone metabolism following total hip and total knee total joint replacement. Pathobiology 2002;70:26–33.
   PubMed Web of Science ®Google Scholar
• Bowe EA, Murray RC, Jeffcott LB, Davies ME. Do the matrix degrading enzymes cathepsins B and D increase following a high intensity exercise regime? Osteoarthritis Cartilage 2007;15:343–9.
   PubMed Web of Science ®Google Scholar
• Olszewska D, Drewa T, Makarewicz R, Drewa J, Wozniak A, Maciak R. Significance of cathepsin B and D in physiologic and pathologic processes. Pol Merk Lek 2001;10:65–70.
   PubMedGoogle Scholar
• Otsuki S, Hanson SR, Miyaki S, Grogan SP, Kinoshita M, Asahara H, Wong CH, Lotz MK. Extracellular sulfatases support cartilage homeostasis by regulating BMP and FGF signaling pathways. Proc Natl Acad Sci USA 2010;107: 10202–7.
   PubMed Web of Science ®Google Scholar
• Yamaguchi R, Yamamoto T, Motomura G, Ikemura S, Iwasaki K, Zhao G, Doi T, Iwamoto Y. Bone and cartilage metabolism markers in synovial fluid of the hip joint with secondary osteoarthritis. Rheumatology (Oxford) 2014; 53:2191–5.
   PubMed Web of Science ®Google Scholar
• Olszewska-Slonina D, Matewski D, Jung S, Olszewski KJ, Czajkowski R, Braszkiewicz J, Wozniak A, Kowaliszyn B. The activity of cathepsin D and alpha-1 antitrypsin in hip and knee osteoarthritis. Acta Biochim Pol 2013;60:99–106.
   PubMed Web of Science ®Google Scholar
• Drewa T, Olszewska D, Makarewicz R, Drewa J, Wozniak A, Kowalke K. The significance of cathepsins B and D and their inhibitors in cancer disease. Pol Merk Lek 2001;11:88–90.
   PubMedGoogle Scholar
• Yamabe S, Hirose J, Uehara Y, Okada T, Okamoto N, Oka K, Taniwaki T, Mizuta H. Intracellular accumulation of advanced glycation end products induces apoptosis via endoplasmic reticulum stress in chondrocytes. FEBS J 2013;280:1617–29.
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265–75.
   PubMed Web of Science ®Google Scholar
• Bleszynski W, Dzialoszynski LM. Purification of soluble arylsulphatase from ox brain. Biochem J 1965; 97:360–4.
   PubMed Web of Science ®Google Scholar
• Bessey OA, Lowry OH, Brock MJ. A method for the rapid determination of alkaline phosphatase with five cubic millimeters of serum J Biol Chem 1946;164:321–3.
   Google Scholar
• Mycek KJ. Cathepsins. In: Perlmann GE, Lorand L, editors. Methods in enzymology. New York: Academic Press; 1970. pp 285–315.
   Google Scholar
• Kahn MJ, Schandevijl W, Philipi G, Frank HL. The contribution of alpha1-antitrypsin to the total antitrypsin activity of human serum. A study of two phenotype PI OO individuals. Clin Chim Acta 1977;80:513–8.
   PubMed Web of Science ®Google Scholar
• Malemud CJ, Islam N, Haqqi TM. Pathophysiological mechanisms in osteoarthritis lead to novel therapeutic strategies. Cells Tissues Organs 2003;174:34–48.
   PubMed Web of Science ®Google Scholar
• Testa V, Capasso G, Maffulli N, Sgambato A, Ames PR. Proteases and antiproteases in cartilage homeostasis. A brief review. Clin Orthop Relat Res 1994;308:79–84.
   PubMedGoogle Scholar
• National Register of Hip and Knee Implants, Warsaw, 2012, National Health Found.
   Google Scholar
• Matveeva EL, Gasanova AG, Spirkina ES. [The biochemical composition of synovial liquid of human knee joint in normal condition (indicators of electrolytes and protein specter)]. Klin Lab Diagn 2012;4:14–6.
   PubMedGoogle Scholar
• Kar NC, Cracchiolo A 3rd, Mirra J, Pearson CM. Acid, neutral, and alkaline hydrolases in arthritic synovium. Am J Clin Pathol 1976;65:220–8.
   PubMed Web of Science ®Google Scholar
• Tuchocka-Piotrowska A. Pharmacological options of osteoarthritis therapy. Przew Lek 2007;3:60–71.
   Google Scholar
• Sipe JD. Acute-phase proteins in osteoarthritis. Semin Arthritis Rheum 1995;25:75–86.
   PubMed Web of Science ®Google Scholar
• Lewis EC. Expanding the clinical indications for α(1)-antitrypsin therapy. Mol Med 2012;18:957–70.
   PubMed Web of Science ®Google Scholar
• Sun JM, Sun LZ, Liu J, Su BH, Shi L. Serum interleukin-15 levels are associated with severity of pain in patients with knee osteoarthritis. Dis Markers 2013;35:203–6.
   PubMed Web of Science ®Google Scholar
• Brömme D, Kaleta J. Thiol-dependent cathepsins: pathophysiological implications and recent advances in inhibitor design. Curr Pharm Des 2002;8:1639–58.
   PubMed Web of Science ®Google Scholar
• Lis K, Odrowaz-Sypniewska G. Role of cathepsin K in the pathogenesis of degenerative changes in joints. Ortop Traumatol Rehabil 2005;7:361–4.
   PubMedGoogle Scholar
• Mantle D, Falkous G, Walker D. Quantification of protease activities in joint fluid from rheumatoid and osteoarthritis cases: comparison with antioxidant and free radical damage markers. Clin Chim Acta 1999;284:45–58.
   PubMed Web of Science ®Google Scholar
• Baggiolini M, Schnyder J, Bretz U, Dewald B, Ruch W. Cellular mechanisms of proteinase release from inflammatory cells and the degradation of extracellular proteins. Ciba Found Symp 1979;75:105–21.
   PubMedGoogle Scholar
• Takahashi T, Kitaoka K, Ogawa Y, Kobayashi T, Seguchi H, Tani T, Yoshida S. Lysosomal dysfunction on hydrogen peroxide-induced apoptosis of osteoarthritic chondrocytes. Int J Mol Med 2004;14:197–200.
   PubMed Web of Science ®Google Scholar
• Niissalo S, Li TF, Santavirta S, Takagi M, Hietanen J, Konttinen YT. Dense innervation in pseudocapsular tissue compared to aneural interface tissue in loose totally replaced hips. J Rheumatol 2002;29:796–803.
   PubMed Web of Science ®Google Scholar
• Gobezie R, Kho A, Krastins B, Sarracino DA, Thornhill TS, Chase M, Millett PJ, Lee DM. High abundance synovial fluid proteome: distinct profiles in health and osteoarthritis. Arthritis Res Ther 2007;9:R36.
   PubMed Web of Science ®Google Scholar
• Salvati EA, Granda JL, Mirra J, Wilson PD Jr. Clinical, enzymatic and histological study of synovium in coxarthrosis. Int Orthop 1977;1:39–42.
   Web of Science ®Google Scholar
• Schartz ER, Ogle RC, Thompson RC. Aryl sulfatase activities in normal and pathologic human articular cartilage. Arthritis Rheum 1974;17:455–67.
   PubMedGoogle Scholar
• Seol JW, Lee HB, Kim NS, Park SY. Tartrate-resistant acid phosphatase as a diagnostic factor for arthritis. Int J Mol Med 2009;24:57–62.
   PubMed Web of Science ®Google Scholar